| 摘要 |
PURPOSE:To accurately examine the coagulation fibrinogenolysis system of the blood sample preserved for a certain period of a fibrinogenolysis activator administered patient by preliminarily putting an anticoagulant and an anti- fibrinogenolysis agent in a container to suppress the action of a fibrinogenolysis agent. CONSTITUTION:When t-PA (tissue plasminogen) administered during medical treatment is present in the plasma of a patient, the decomposition of fibrinogen or the decomposition/consumption of plasminogen is generated by the action of t-PA and the clinical examination of a coagulation fibrinogenolysis system is inhibited. When an anti-fibrinogenolysis agent is added to a blood collecting container other than an anticoagulant, said agent inhibits the plasminogen activating action of t-PA. Therefore, even when the plasma of a t-PA administered patient is preserved for a certain period, the change of the value of the component such as fibrinogen or plasminogen in said plasma can be prevented. |
